Genmab A/S
CPSE:GMAB
kr 1.713,00
+ kr24,50 (1,45%)
1.713,00 kr
+kr24,50 (1,45%)
End-of-day quote: 03/31/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
14,29%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
-4,48%
Outlook 12/26
W
54,09%
Margin of safety
T
37,19%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
9,16%
Revenue growth 5Y
19,84%
Price growth 5Y
-17,92%
Market Cap
kr105,16 B
Long-Term Debt
kr31,81 B
Quarterly earnings
05/08/2026 (E)
Dividend
kr0,00
Dividend Yield
0,00%
Industry
Country
Website
ISIN Number

Genmab A/S Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr2.350,00
37.19%
37.19
Last Update: 04/01/2026
Analysts: 14

Highest Price Target kr3.017,00

Average Price Target kr2.350,00

Lowest Price Target kr1.300,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Genmab A/S
CPSE:GMAB
-17,92% -17,92% 0,00% 14,29% 4/6 -4,48% 54,09% 37,19% DOWN
×